Intellectual Property - May 4, 2026
Gradientech receives US patent allowance
Gradientech has received a Notice of Allowance in the United States for its single-use microfluidic test, a key component of the CE marked QuickMIC system.
Intellectual Property - March 11, 2026
AnaCardio announces issuance of US patent for AC01
The patent covers the use of AC01 for the treatment of heart failure with reduced ejection fraction (HFrEF).
Intellectual Property - March 11, 2026
Alligator Bioscience strengthens intellectual property protection
The United States Patent and Trademark Office (USPTO) has granted a patent covering Alligator’s bispecific antibody format.
Intellectual Property - February 25, 2026
Salipro Biotech obtains key US patent grant
The new patent secures long term protection for the Salipro platform technologies, extending exclusivity until 2042 and reinforcing the company’s position as a premier partner for drug discovery against challenging drug targets.
Intellectual Property - January 7, 2026
Mucocort granted Swedish patent
The company has received a notice of approval for a Swedish patent covering the antimicrobial mechanism of action in its treatment patch, M045A, developed for the treatment of oral ulcers caused by aphthae (Recurrent Aphthous Stomatitis). The patent approval strengthens the company’s intellectual property portfolio and represents an important milestone ahead of the international PCT […]
Intellectual Property - October 21, 2025
Alligator Bioscience granted US patent
The United States Patent and Trademark Office has granted a patent covering the composition of matter of ATOR-4066, the company’s bispecific antibody targeting CD40 and CEACAM5.
